QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative breast cancer (MDA-MB-231 cell line) drug compounds
Crossref DOI link: https://doi.org/10.1186/s42269-021-00541-x
Published Online: 2021-05-17
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lawal, Hadiza Abdulrahman http://orcid.org/0000-0001-5086-2344
Uzairu, Adamu
Uba, Sani
Text and Data Mining valid from 2021-05-17
Version of Record valid from 2021-05-17
Article History
Received: 27 May 2020
Accepted: 14 April 2021
First Online: 17 May 2021
Declarations
:
: Not applicable.
: The authors declare no competing interest.